For patients with MDS, identification of mutations in genes including TET2, SF3B1, ASXL1 and TP53 is particularly useful to help establish clonal hematopoiesis to make a definitive diagnosis of MDS [4]. This evidence concerns the gene TP53 and myelodysplastic syndrome.